References
- Evers LH, Bhavsar D, Mailänder P. The biology of burn injury. Exp Dermatol. 2010;19:777–783.
- Jeschke MG, Gauglitz GG, Kulp GA, et al. Long-term persistance of the pathophysiologic response to severe burn injury. PLoS One. 2011;6:e21245.
- Huang Y, Li Z, Yang Z. Roles of ischemia and hypoxia and the molecular pathogenesis of post-burn cardiac shock. Burns. 2003;29:828–833.
- Li T, Yu R, Zhang H-H, et al. A method for purification and viral inactivation of human placenta hemoglobin. Artif Cells Blood Substit Immobil Biotechnol. 2006;34:175–188.
- Li T, Jiang Y, Zhang Z, et al. Effect of polymerized human placenta hemoglobin on hemodynamic parameter and cardiac function in a rat hemorrhagic shock model. Artif Cells Blood Substit Immobil Biotechnol. 2012;40:256–260.
- Li T, Li J, Liu J, et al. Polymerized placenta hemoglobin attenuates ischemia/reperfusion injury and restores the nitroso-redox balance in isolated rat heart. Free Radic Biol Med. 2009a;46:397–405.
- Li T, Liu J, Yang Q, et al. Polymerized placenta hemoglobin improves cardiac functional recovery and reduces infarction size of isolated rat heart. Artif Cells Blood Substit Immobil Biotechnol. 2009;37:48–52.
- Li T, Zhang P, Liu J, et al. Protective effects of hemoglobin-based oxygen carrier given to isolated heart during ischemia via attenuation of mitochondrial oxidative damage. Free Radic Biol Med. 2010;48:1079–1089.
- Li T, Zhou R, Xiang X, et al. Polymerized human placenta hemoglobin given before ischemia protects rat heart from ischemia reperfusion injury. Artif Cells Blood Substit Immobil Biotechnol. 2011;39:392–397.
- Wu W, Li T, Liu J, et al. Pretreatment before ischemia induction with polymerized human placenta hemoglobin (PolyPHb) attenuates ischemia/reperfusion injury-induced myocardial apoptosis. Artif Cells Blood Substit Immobil Biotechnol. 2011;39:3–6.
- You Z, Li Q, Li B, et al. Isovolemic hemodilution with glutaraldehyde-polymerized human placenta hemoglobin (PolyPHb) attenuated rat liver ischemia/reperfusion injury. Artif Cells Nanomed Biotechnol. 2013;42:83–87.
- Li T, Zhou R, Yao Y, et al. Angiotensin-converting enzyme inhibitor captopril reverses the adverse cardiovascular effects of polymerized hemoglobin. Antioxid Redox Signal. 2014;21:2095–2108.
- Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115:1285–1295.
- Nielson CB, Duethman NC, Howard JM, et al. Burns: pathophysiology of systemic complications and current management. J Burn Care Res. 2017;38:e469–e481.
- Li T, Zhang Z, Wu W, et al. Resuscitation with polymerized human placenta hemoglobin attenuated hemorrhagic shock-induced lung injury. Artif Cells Nanomed Biotechnol. 2013;41:27–31.
- Li T, Zhang Z, Liao D, et al. The effect of polymerized placenta hemoglobin on renal ischemia/reperfusion injury. Artif Cells Blood Substit Immobil Biotechnol. 2012b;40:396–399.
- Soltero RG, Hansbrough JF. The effects of diaspirin cross-linked hemoglobin on hemodynamics, metabolic acidosis and survival in burned rats. J Trauma. 1999;46:286–291.
- Brocq ML, Leslie SJ, Milliken P, et al. Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications and therapeutic opportunities. Antioxid Redox Signal. 2008;10:1631–1674.
- Frantz S, Nahrendorf M. Cardiac macrophages and their role in ischaemic heart disease. Cardiovasc Res. 2014;102:240–248.
- Preiser JC, Reper P, Vlasselaer D, et al. Nitric oxide production is increased in patients after burn injury. J Trauma. 1996;40:368–371.
- Rawlingson A. Nitric oxide, inflammation and acute burn injury. Burns. 2003;29:631–640.